Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Prochazka Katharina |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2023
Editorial
** Prochazka, KT
Best of hematology-2021
MEMO-MAG EUR MED ONC. 2023; 16(1): 36-37.
Doi: 10.1007/s12254-022-00826-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Originalarbeit (Zeitschrift)
** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14):
Doi: 10.3390/ijms23147874
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Prochazka, KT; Uhl, B
Bcl2 inhibitor venetoclax +/- Anti-CD20: what do deep remissions mean?
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-021-00778-2
Web of Science
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Fechter, K; Pansy, K; Greinix, HT; Neumeister, P; Deutsch, AJ
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.
World J Gastrointest Oncol. 2022; 14(1): 153-162.
Doi: 10.4251/wjgo.v14.i1.153
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Originalarbeit (Zeitschrift)
** Gao, YT; Wei, L; Kim, SJ; Wang, L; He, YZ; Zheng, YF; Bertero, L; Pellerino, A; Cassoni, P; Tamagnone, L; Prochazka, KT; Deutsch, A; Zhan, HE; Lai, J; Wang, Y; You, H
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
FRONT ONCOL. 2021; 11: 696147
Doi: 10.3389/fonc.2021.696147
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, C; Neumeister, P; Schulz, E
Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
Hemasphere. 2021; 5(8): e621
Doi: 10.1097/HS9.0000000000000621
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207
Doi: 10.1007/s00520-021-06059-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Prochazka, KT; Neumeister, P
Chronic lymphocytic leukaemia-what is new and notable in 2021, with a special focus on COVID-19.
Memo. 2021; 1-4
Doi: 10.1007/s12254-021-00735-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Originalarbeit (Zeitschrift)
** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT
Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283
Doi: 10.1002/hon.2727
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT
The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833
Doi: 10.1007/s12253-020-00864-6
Web of Science
PubMed
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Sedej, M; Roula, D; Pursche, B; Wolf, A; Zoidl, M; Steinbauer, E; Gruber, V; Greinix, HT; Prochazka, KT; Thallinger, GG; Heinemann, A; Beham-Schmid, C; Neumeister, P; Wrodnigg, TM; Fechter, K; Deutsch, AJ
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Int J Mol Sci. 2019; 20(19):
Doi: 10.3390/ijms20194740
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prochazka, KT; Pregartner, G; Rücker, FG; Heitzer, E; Pabst, G; Wölfler, A; Zebisch, A; Berghold, A; Döhner, K; Sill, H
Clinical implications of subclonal TP53 mutations in acute myeloid leukemia.
Haematologica. 2019; 104(3):516-523
Doi: 10.3324/haematol.2018.205013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Originalarbeit (Zeitschrift)
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528
Doi: 10.1038/s41598-018-32972-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Prochazka, KT; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Abdyli, L; Greinix, H; Pichler, M; Neumeister, P
Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
Br J Haematol. 2018; 183(1):142-146
Doi: 10.1111/bjh.14912
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J
Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.
Blood Cancer J. 2018; 8(9): 79-79.
Doi: 10.1038/s41408-018-0112-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Bergmann, TC; Pursche, B; Greinix, H; Neumeister, P; Deutsch, A; Prochazka, K
Overexpression of miR199a and miR497 regulates Nf-kappa B and B-cell receptor signalling in diffuse large B-cell lymphoma (DLBCL)
ONCOL RES TREAT. 2018; 41: 81-82.
[Poster]
Web of Science
** Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P
Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82.
[Poster]
Web of Science
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
** Pabst G, Prochazka K, Pregartner G, Rücker FG, Heitzer E, Woelfler A, Zebisch A, Berghold A, Döhner K and Sill H.
Impact of TP53 mutated subclones in acute myeloid leukemia
Blood. 2018; 132(Suppl ):-Annual Meeting of the American Society of Hematology; December 1-4, 2018; San Diego.
Doi: 10.1182/blood-2018-99-110667
[Poster]
Web of Science
FullText
FullText_MUG
** Panny, M; Prochazka, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Holzer, K; Bohm, A; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R- the Austrian experience
ONCOL RES TREAT. 2018; 41: 46-46.
[Poster]
Web of Science
** Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A
Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81.
[Poster]
Web of Science
** Prochazka, K
CLL: State of the Art Therapy, First-line therapy
ONCOL RES TREAT. 2018; 41: 266-266.
Web of Science
** Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P
Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50.
[Poster]
Web of Science
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164.
[Poster]
Web of Science
2017
Originalarbeit (Zeitschrift)
** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386
Doi: 10.1158/0008-5472.CAN-16-2320
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fallbericht
** Kirsch, AH; Pollheimer, MJ; Troppan, K; Horina, JH; Rosenkranz, AR; Eller, K
The Case | Acute kidney injury and hemolysis in a 58-year-old woman.
Kidney Int. 2017; 91(4): 993-994.
Doi: 10.1016/j.kint.2016.09.008
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
** Panny, M; Prochazka, K; Holzer, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Greinix, H; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis
ONCOL RES TREAT. 2017; 40: 69-70.
[Poster]
Web of Science
2016
Originalarbeit (Zeitschrift)
** Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272
Doi: 10.1038/bjc.2016.325
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330
Doi: 10.1136/jclinpath-2015-203356
Web of Science
PubMed
FullText
FullText_MUG
** Wenzl, K; Hofer, S; Troppan, K; Lassnig, M; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Neumeister, P; Deutsch, A
Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas.
Tumour Biol. 2016; 37(4):4785-4789
Doi: 10.1007/s13277-015-4322-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Deak, AT; Troppan, K; Rosenkranz, AR
Anemia management in cancer patients with chronic kidney disease.
Eur J Intern Med. 2016; 36(4):13-19
Doi: 10.1016/j.ejim.2016.08.036
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Panny, M; Troppan, K; Neumeister, P; Nosslinger, T; Holzer, K; Greinix, H; Keil, F
TREATMENT OF HIGH RISK AGGRESSIVE B CELL LYMPHOMAS WITH DA EPOCH R- A RETROSPECTIVE ANALYSIS
HAEMATOLOGICA. 2016; 101: 698-698.-21st Congress of the European-Hematology-Association; JUN 09-12, 2016; Copenhagen, DENMARK.
[Poster]
Web of Science
** Troppan, K; Beham, C; Greinix, H; Deutsch, A; Neumeister, P;
DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY.
HAEMATOLOGICA. HAEMATOLOGICA101: 396-397. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, JUN 09-12, 2016)
Web of Science
** Troppan, K; Pregartner, G; Zach, V; Greinix, H; Neumeister, P
Identification of prognostic factors in patients with mature lymphoid malignancies undergoing autologous stem cell transplantation-a single center experience
BONE MARROW TRANSPL. 2016; 51: S506-S506.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
[Poster]
Web of Science
2015
Originalarbeit (Zeitschrift)
** Froehlich, EV; Rinner, B; Deutsch, AJ; Meditz, K; Knausz, H; Troppan, K; Scheipl, S; Wibmer, C; Leithner, A; Liegl, B; Lohberger, B
Examination of survivin expression in 50 chordoma specimens--A histological and in vitro study.
J Orthop Res. 2015; 33(5):771-778
Doi: 10.1002/jor.22819
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Hopfinger, G; Magnes, T; Deutsch, A; Neumeister, P; Hackl, H; Greil, R; Pichler, M; Egle, A
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Br J Haematol. 2015; 168(2):239-245
Doi: 10.1111/bjh.13116
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
J Natl Compr Canc Netw. 2015; 13(12):1501-1508
Doi: 10.6004/jnccn.2015.0178
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Hofer, S; Wenzl, K; Lassnig, M; Pursche, B; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Deutsch, A; Neumeister, P
Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
PLoS One. 2015; 10(4):e0123922-e0123922
Doi: 10.1371/journal.pone.0123922
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, GG; Beham-Schmid, C; Neumeister, P; Deutsch, A
miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Int J Mol Sci. 2015; 16(8):18077-18095
Doi: 10.3390/ijms160818077
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Eur J Haematol. 2015; 95(6):538-544
Doi: 10.1111/ejh.12529
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Neumeister, P; Troppan, K; Raderer, M
Management of gastric mucosa-associated lymphoid tissue lymphoma.
Dig Dis. 2015; 33(1):11-18
Doi: 10.1159/000366030
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Wenzl, K; Neumeister, P; Deutsch, A
Molecular Pathogenesis of MALT Lymphoma.
Gastroenterol Res Pract. 2015; 2015(9):102656-102656
Doi: 10.1155/2015/102656
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzl, K; Troppan, K; Neumeister, P; Deutsch, AJ
The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
Curr Drug Targets. 2015; 16(1):38-46
Doi: 10.2174/1389450115666141120112818
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Beham-Schmid, C; Neumeister, P
NR4A1 AND NR4A3 POSSESS FUNCTIONAL REDUNDANCY BY REGULATING PRO-APOPTOTIC GENES IN AGGRESSIVE LYMPHOMAS.
HAEMATOLOGICA. 2015; 100: 544-544.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
** Deutsch, AJA; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Greinix, HT; Beham-Schmid, C; Neumeister, P
NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64.
[Poster]
Web of Science
** Troppan, K; Wenzl, K; Neumeister, P; Beham-Schmid, C; Przekopowitz, M; Greinix, HT; Schaider, H; Deutsch, AJA
The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Pursche, B; Bischof, M; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, AJA
Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
2014
Originalarbeit (Zeitschrift)
** Deutsch, AJ; Rinner, B; Wenzl, K; Pichler, M; Troppan, K; Steinbauer, E; Schwarzenbacher, D; Reitter, S; Feichtinger, J; Tierling, S; Prokesch, A; Scheideler, M; Krogsdam, A; Thallinger, GG; Schaider, H; Beham-Schmid, C; Neumeister, P
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Blood. 2014; 123(15):2367-2377
Doi: 10.1182/blood-2013-08-518878
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Duettmann, W; Koidl, C; Troppan, K; Seeber, K; Buzina, W; Wölfler, A; Wagner, J; Krause, R; Hoenigl, M
Serum and urine galactomannan testing for screening in patients with hematological malignancies.
Med Mycol. 2014; 52(6):647-652
Doi: 10.1093/mmy/myu019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Deutsch, A; Gerger, A; Stojakovic, T; Beham-Schmid, C; Wenzl, K; Neumeister, P; Pichler, M
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Br J Cancer. 2014; 110(2):369-374
Doi: 10.1038/bjc.2013.763
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Br J Cancer. 2014; 111(1):55-60
Doi: 10.1038/bjc.2014.277
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Valentin, A; Troppan, K; Pfeilstöcker, M; Nösslinger, T; Linkesch, W; Neumeister, P
Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
Leuk Lymphoma. 2014; 55(8):1739-1742
Doi: 10.3109/10428194.2013.853765
Web of Science
PubMed
FullText
FullText_MUG
Übersichtsarbeit
** Troppan, K; Wenzl, K; Deutsch, A; Ling, H; Neumeister, P; Pichler, M
MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(2):557-564
Web of Science
PubMed
Abstract (Zeitschrift)
** Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Beham-Schmid, C; Neumeister, P
NR4A3-MEDIATED APOPTOSIS SUPPRESSES LYMPHOMAGENESIS IN A XENOGRAFT MOUSE MODEL
HAEMATOLOGICA. .. 2014; 99: 136-136.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
** Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P
HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135.
[Poster]
Web of Science
** Troppan, KT; Wenzl, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells
ONCOL RES TREAT. 2014; 37: 72-73.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Deutsch, A; Neumeister, P
ANALYSES OF NUCLEAR ORPHAN RECEPTOR EXPRESSION AND CYTOTOXICITY FOLLOWING ANTI-CD 20 MONOCLONAL ANTIBODY TREATMENT IN AGGRESSIVE NON-HODGKIN'S LYMPHOMAS
HAEMATOLOGICA. 2014; 99: 685-686.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival
ONCOL RES TREAT. 2014; 37: 73-73.
[Poster]
Web of Science
2013
Originalarbeit (Zeitschrift)
** Hoenigl, M; Duettmann, W; Raggam, RB; Seeber, K; Troppan, K; Fruhwald, S; Prueller, F; Wagner, J; Valentin, T; Zollner-Schwetz, I; Wölfler, A; Krause, R
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.
Antimicrob Agents Chemother. 2013; 57(7):3262-3267
Doi: 10.1128/AAC.00251-13
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Unteregger, M; Valentin, A; Zinke-Cerwenka, W; Troppan, K; Deutsch, A; Cerroni, L; Linkesch, W; Neumeister, P
Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm.
Bone Marrow Transplant. 2013; 48(6):799-802
Doi: 10.1038/bmt.2012.242
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, J; Schilcher, G; Zollner-Schwetz, I; Hoenigl, M; Valentin, T; Ribitsch, W; Horina, J; Rosenkranz, AR; Grisold, A; Unteregger, M; Troppan, K; Valentin, A; Neumeister, P; Krause, R
Microbiological screening for earlier detection of central venous catheter-related bloodstream infections.
Eur J Clin Invest. 2013; 43(9):964-969
Doi: 10.1111/eci.12126
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Wenzl, K; Troppan, K; Deutsch, AJA; Linkesch, W; Neumeister, P; Beham-Schmid, C;
Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas.
BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013)
Doi: 10.1182/blood.V122.21.4852.4852
Web of Science
FullText
FullText_MUG
2012
Abstract (Zeitschrift)
** Deutsch, AJA; Pichler, M; Reitter, S; Troppan, K; Beham-Schmid, C; Neumeister, P;
Reduction of NR4A1 is associated with poor survival aggressive lymphomas.
ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart.
[Oral Communication]
Web of Science
** Valentin, A; Unteregger, M; Troppan, K; Zinke-Cerwenka, W; Cerroni, L; Linkesch, W; Neumeister, P;
Unrelated stem cell transplantation induces long term disease control in patients with blastic plasmocytoid dendritic cell neoplasm.
ONKOLOGIE. 2012; 35: 212-213.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart.
[Poster]
Web of Science
2010
Originalarbeit (Zeitschrift)
** Stelzl, E; Troppan, KT; Winkler, M; Korn, K; Kessler, HH
Optimized protocol for detection of HIV-1 drug mutations in patients with low viral load.
J VIROL METH. 2010; 168(1-2): 152-154.
Doi: 10.1016/j.jviromet.2010.05.007
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Bozic, M; Santner, BI; Kessler, HH
Evaluation of four molecular assays for detection of pandemic influenza A (H1N1) 2009 virus in the routine diagnostic laboratory.
J CLIN VIROL. 2010; 49(2): 82-84.
Doi: 10.1016/j.jcv.2010.07.012
Web of Science
PubMed
FullText
FullText_MUG
2009
Originalarbeit (Zeitschrift)
** Troppan, KT; Stelzl, E; Violan, D; Winkler, M; Kessler, HH
Evaluation of the new VERSANT HIV-1 RNA 1.0 Assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA.
J CLIN VIROL. 2009; 46(1): 69-74.
Doi: 10.1016/j.jcv.2009.06.012
Web of Science
PubMed
FullText
FullText_MUG